Near-infrared optical imaging of proteases in cancer

Molecular Cancer Therapeutics

Volumn 2, Issue 5, 2003, Pages 489-496

  Mahmood, Umar ^a   Weissleder, Ralph ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0344438130     PISSN: 15357163     EISSN: 15388514     Source Type: Journal    
DOI: None     Document Type: Short Survey

References (69)

1. Weissleder, R., and Mahmood, U. Molecular imaging, Radiology, 219: 316-333, 2001. (Pubitemid 32336342)
2. Buchsbaum, D. J. Experimental tumor targeting with radiolabeled ligands. Cancer (Phila.), 80: 2371-2377, 1997. (Pubitemid 28009488)
3. Tyagi, S., and Kramer, F. R. Molecular beacons: probes that fluoresce upon hybridization. Nat. Biotechnol., 14: 303-308, 1996.
4. Tyagi, S., Bratu, D. P., and Kramer, F. R. Multicolor molecular beacons for allele discrimination. Nat. Biotechnol., 16: 49-53, 1998. (Pubitemid 28035948)
5. Kircher, M., Josephson, L., and Weissleder, R. Ratio imaging of enzyme activity using dual wavelength optical reporters. Molecular Imaging, 1: 89-95, 2002.
6. Bogdanov, A., Matuszewski, L., Bremer, C., Petrovsky, A., and Weissleder, R. Oligomerization of paramagnetic substrates result in signal amplification and can be used for MR imaging of molecular targets. Mol. Imaging, 1: 16-23, 2001.
7. Callahan, R., Bogdanov, A., Fischman, A., Brady, T., and Weissleder, R. Preclinical evaluation and Phase I clinical trial of a 99mTc labeled synthetic polymer used in blood pool imaging. Am. J. Roentgenol., 171: 137-143, 1998. (Pubitemid 28308663)
8. Marecos, E., Weissleder, R., and Bogdanov, A., Jr. Antibody-mediated versus nontargeted delivery in a human small cell lung carcinoma model. Bioconjug. Chem., 9: 184-191, 1998. (Pubitemid 28147135)
9. Keppler, D., Sameni, M., Moin, K., Mikkelsen, T., Diglio, C., and Sloane, B. Tumor progression and angiogenesis: cathepsin B & Co. Biochem. Cell Biol., 74: 799-810, 1996. (Pubitemid 126733741)
10. Kim, J., Yu, W., Kovalski, K., and Ossowski, L. Requirement for specific proteases in cancer cell intravasation as revealed by a novel semiquantitative PCR-based assay. Cell., 94: 353-362, 1998. (Pubitemid 28376079)
11. Liaudet, E., Derocq, D., Rochefort, H., and Garcia, M. Transfected cathepsin D stimulates high density cancer cell growth by inactivating secreted growth inhibitors. Cell Growth Differ., 6: 1045-1052, 1995.
12. Garcia, M., Platet, N., Liaudet, E., Laurent, V., Derocq, D., Brouillet, J., and Rochefort, H. Biological and clinical significance of cathepsin D in breast cancer metastasis. Stem Cells, 14: 642-650, 1995.
13. Yavelow, J., Finlay, T. H., Kennedy, A. R., and Troll, W. Bowman-Birk soybean protease inhibitor as an anticarcinogen. Cancer Res., 43: 2454s-2459s, 1983.
14. Yu, A. E., Hewitt, R. E., Connor, E. W., and Stetler-Stevenson, W. G. Matrix metalloproteinases. Novel targets for directed cancer therapy. Drugs Aging, 11: 229-244, 1997. (Pubitemid 27421320)
15. Wojtowicz-Praga, S. M., Dickson, R. B., and Hawkins, M. J. Matrix metalloproteinase inhibitors. Investig. New Drugs., 15: 61-75, 1997. (Pubitemid 27217752)
16. Tamura, Y., Watanabe, F., Nakatani, T., Yasui, K., Fuji, M., Komurasaki, T., Tsuzuki, H., Maekawa, R., Yoshioka, T., Kawada, K., Sugita, K., and Ohtani, M. Highly selective and orally active inhibitors of type IV collagenase (MMP-9 and MMP-2): N-sulfonylamino acid derivatives. J. Med. Chem., 41: 640-649, 1998. (Pubitemid 28093097)
17. Moin, K., Demchik, L., Mai, J., Duessing, J., Peters, C., and Sloane, B. F. Observing proteases in living cells. Adv. Exp. Med. Biol., 477: 391-401, 2000. (Pubitemid 32174024)
18. Reinheckel, T., Deussing, J., Roth, W., and Peters, C. Towards specific functions of lysosomal cysteine peptidases: phenotypes of mice deficient for cathepsin B or cathepsin L. Biol. Chem. 382: 735-741, 2001. (Pubitemid 32631710)
19. Redwood, S. M., Liu, B. C., Weiss, R. E., Hodge, D. E., and Droller, M. J. Abrogation of the invasion of human bladder tumor cells by using protease inhibitor(s). Cancer (Phila.), 69: 1212-1219, 1992.
20. Navab, R., Mort, J. S., and Brodt, P. Inhibition of carcinoma cell invasion and liver metastases formation by the cysteine proteinase inhibitor E-64. Clin. Exp. Metastasis, 15: 121-129, 1997. (Pubitemid 27157814)
21. Coulibaly, S., Schwihla, H., Abrahamson, M., Albini, A., Cerni, C., Clark, J. L., Ng, K. M., Katunuma, N., Schlappack, O., Glossl, J., and Mach, L. Modulation of invasive properties of murine squamous carcinoma cells by heterologous expression of cathepsin B and cystatin C. Int. J. Cancer, 83: 526-531, 1999. (Pubitemid 29489869)
22. Maguire, T. M., Shering, S. G., Duggan, C. M., McDermott, E. W., O'Higgins, N. J., and Duffy, M. J. High levels of cathepsin B predict poor outcome in patients with breast cancer. Int. J. Biol. Markers, 13: 139-144, 1998. (Pubitemid 29092522)
23. Benitez-Bribiesca, L., Martinez, G., Ruiz, M. T., Gutierrez-Delgado, F., and Utrera, D. Proteinase activity in invasive cancer of the breast. Correlation with tumor progression. Arch. Med. Res., 26: S163-S168, 1995. (Pubitemid 26044948)
24. Poole, A. R., Tiltman, K. J., Recklies, A. D., and Stoker, T. A. Differences in secretion of the proteinase cathepsin B at the edges of human breast carcinomas and fibroadenomas. Nature (Lond.), 273: 545-547, 1978. (Pubitemid 8346587)
25. Bremer, C., Tung, C. H., Bogdanov, A., Moore, A., and Weissleder, R. Imaging of differential protease expression in breast cancers for detection of aggressive tumor phenotypes. Radiology, 222: 814-818, 2002. (Pubitemid 34218157)
26. Campo, E., Munoz, J., Miquel, R., Palacin, A., Cardesa, A., Sloane, B. F., and Emmert-Buck, M. R. Cathepsin B expression in colorectal carcinomas correlates with tumor progression and shortened patient survival. Am. J. Pathol., 145: 301-309, 1994. (Pubitemid 24245830)
27. Ebert, W., Knoch, H., Werle, B., Trefz, G., Muley, T., and Spiess, E. Prognostic value of increased lung tumor tissue cathepsin B. Anticancer Res., 14: 895-899, 1994. (Pubitemid 24272541)
28. Sukoh, N., Abe, S., Ogura, S., Isobe, H., Takekawa, H., Inoue, K., and Kawakami, Y. Immunohistochemical study of cathepsin B. Prognostic significance in human lung cancer. Cancer (Phila.), 74: 46-51, 1994. (Pubitemid 24187608)
29. Foekens, J. A., Kos, J., Peters, H. A., Krasovec, M., Look, M. P., Cimerman, N., Meijer-van Gelder, M. E., Henzen-Logmans, S. C., van Putten, W. L., and Klijn, J. G. Prognostic significance of cathepsins B and L in primary human breast cancer. J. Clin. Oncol., 16: 1013-1021, 1998. (Pubitemid 28108735)
30. Weissleder, R., Tung, C. H., Mahmood, U., and Bogdanov, A., Jr. In vivo imaging of tumors with protease-activated near-infrared fluorescent probes. Nat. Biotechnol., 17: 375-378, 1999. (Pubitemid 29166041)
31. Mahmood, U., Tung, C. H., Bogdanov, A., Jr., and Weissleder. R. Near-infrared optical imaging of protease activity for tumor detection, Radiology, 213: 866-870, 1999.
32. Bremer, C., Tung, C. H., and Weissleder, R. In vivo molecular target assessment of matrix metalloproteinase inhibition. Nat. Med., 7: 743-748, 2001. (Pubitemid 32588033)
33. Chen, J., Tung, C. H., Mahmood, U., Ntziachristos, V., Gyurko, R., Fishman, M. C., Huang, P. L., and Weissleder, R. In vivo imaging of proteolytic activity in atherosclerosis. Circulation, 105: 2766-2771, 2002. (Pubitemid 34615149)
34. Ji, H., Ohmura, K., Mahmood, U., Lee, D., Hofhuis, F., Boackle, S., Takahashi, K., Holers, V., Walport, M., Gerard, C., Ezekowitz, A., Carroll, M., Brenner, M., Weissleder, R., Verbeek, J., Duchatelle, V., Degott, C., Benoist, C., and Mathis, D. Arthritis critically dependent on innate immune system players. Immunity, 16: 157-168, 2002. (Pubitemid 34211957)
35. Tung, C. H., Mahmood, U., Bredow, S., and Weissleder, R. In vivo imaging of proteolytic enzyme activity using a novel molecular reporter. Cancer Res., 60: 4953-4958, 2000.
36. Tung, C. H., Bredow, S., Mahmood, U., and Weissleder, R. Preparation of a cathepsin D sensitive near-infrared fluorescence probe for imaging. Bioconjug Chem., 10: 892-896, 1999. (Pubitemid 29456379)
37. Escot, C., Zhao, Y., Puech, C., and Rochefort, H. Cellular localisation by in situ hybridisation of cathepsin D, stromelysin 3, and urokinase plasminogen activator RNAs in breast cancer. Breast Cancer Res. Treat., 38: 217-226, 1996. (Pubitemid 26102149)
38. Roger, P., Montcourrier, P., Maudelonde, T., Brouillet, J. P., Pages, A., Laffargue, F., and Rochefort, H. Cathepsin D immunostaining in paraffin-embedded breast cancer cells and macrophages: correlation with cytosolic assay. Hum. Pathol., 25: 863-871, 1994. (Pubitemid 24292401)
39. Garcia, M., Derocq, D., Pujol, P., and Rochefort, H. Overexpression of transfected cathepsin D in transformed cells increases their malignant phenotype and metastatic potency. Oncogene, 5: 1809-1814, 1990. (Pubitemid 120034707)
40. Chambers, A. F., and Matrisian, L. M. Changing views of the role of matrix metalloproteinases in metastasis. J. Natl. Cancer Inst. (Bethesda), 89: 1260-1270, 1997. (Pubitemid 27371946)
41. Stearns, M. E., and Wang, M. Type IV collagenase (Mr 72,000) expression in human prostate: benign and malignant tissue. Cancer Res., 53: 878-883, 1993. (Pubitemid 23077878)
42. Moses, M. A., Wiederschain, D., Loughlin, K. R., Zurakowski, D., Lamb, C. C., and Freeman, M. R. Increased incidence of matrix metallo-proteinases in urine of cancer patients. Cancer Res., 58: 1395-1399, 1998. (Pubitemid 28193598)
43. Sakakibara, M., Koizumi, S., Saikawa, Y., Wada, H., Ichihara, T., Sato, H., Horita, S., Mugishima, H., Kaneko, Y., and Koike, K. Membrane-type matrix metalloproteinase-1 expression and activation of gelatinase A as prognostic markers in advanced pediatric neuroblastoma. Cancer (Phila.), 85: 231-239, 1999. (Pubitemid 29031379)
44. Kanayama, H., Yokota, K., Kurokawa, Y., Murakami, Y., Nishitani, M., and Kagawa, S. Prognostic values of matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-2 expression in bladder cancer. Cancer (Phila.), 82: 1359-1366, 1998. (Pubitemid 28155399)
45. Davidson, B., Goldberg, I., Kopolovic, J., Lerner-Geva, L., Gotlieb, W. H., Ben-Baruch, G., and Reich, R. MMP-2 and TIMP-2 expression correlates with poor prognosis in cervical carcinoma: a clinicopathologic study using immunohistochemistry and mRNA in situ hybridization. Gynecol. Oncol., 73: 372-382, 1999. (Pubitemid 29272858)
46. Murphy, G., Knauper, V., Cowell, S., Hembry, R., Stanton, H., Butler, G., Freije, J., Pendas, A. M., and Lopez-Otin, C. Evaluation of some newer matrix metalloproteinases. Ann. N. Y. Acad. Sci., 878: 25-39, 1999. (Pubitemid 29353558)
47. Shalinsky, D. R., Brekken, J., Zou, H., Bloom, L. A., McDermott, C. D., Zook, S., Varki, N. M., and Appelt, K. Marked antiangiogenic and antitumor efficacy of AG3340 in chemoresistant human non-small cell lung cancer tumors: single agent and combination chemotherapy studies. Clin. Cancer Res., 5: 1905-1917, 1999. (Pubitemid 29334475)
48. Shalinsky, D. R., Brekken, J., Zou, H., McDermott, C. D., Forsyth, P., Edwards, D., Margosiak, S., Bender, S., Truitt, G., Wood, A., Varki, N. M., and Appelt, K. Broad antitumor and antiangiogenic activities of AG3340, a potent and selective MMP inhibitor undergoing advanced oncology clinical trials. Ann. N. Y. Acad. Sci., 878: 236-270, 1999. (Pubitemid 29353575)
49. Rooprai, H. K., and McCormick, D. Proteases and their inhibitors in human brain tumours: a review. Anticancer Res., 17: 4151-4162, 1997. (Pubitemid 28017946)
50. Bremer, C., Bredow, S., Mahmood, U., Weissleder, R., and Tung, C. H. Optical imaging of matrix metalloproteinase-2 activity in tumors: feasibility study in a mouse model. Radiology, 221: 523-529, 2001. (Pubitemid 33043440)
51. Schoenfeld, P., Lipscomb, S., Crook, J., Dominguez, J., Butler, J., Holmes, L., Cruess, D., and Rex, D. Accuracy of polyp detection by gastroenterologists and nurse endoscopists during flexible sigmoidoscopy: a randomized trial. Gastroenterology, 117: 312-318, 1999. (Pubitemid 29352938)
52. Greenlee, R. T., Hill-Harmon, M. B., Murray, T., and Thun, M. Cancer statistics, 2001, CA - Cancer J. Clin., 51: 15-36, 2001. (Pubitemid 32166444)
53. Mayer, R. J. Gastrointestinal tract cancer. In: E. Braunwald, A. S. Fauci, D. L. Kasper, S. L. Hauser, D. L. Longo, and J. L. Jameson (eds.), Harrison's Principles of Internal Medicine, Ed. 15. New York: McGraw Hill, 2001.
54. Winawer, S. J., Fletcher, R. H., Miller, L., Godlee, F., Stolar, M. H., Mulrow, C. D., Woolf, S. H., Glick, S. N., Ganiats, T. G., Bond, J. H., Rosen, L., Zapka, J. G., Olsen, S. J., Giardiello, F. M., Sisk, J. E., Van Antwerp, R., Brown-Davis, C., Marciniak, D. A., and Mayer, R. J. Colorectal cancer screening: clinical guidelines and rationale. Gastroenterology, 112: 594-642, 1997. (Pubitemid 27078848)
55. Atkin, W. S., Morson, B. C., and Cuzick, J. Long-term risk of colorectal cancer after excision of rectosigmoid adenomas. N. Engl. J. Med., 326: 658-662, 1992.
56. O'Brien, M. J., Winawer, S. J., Zauber, A. G., Gottlieb, L. S., Sternberg, S. S., Diaz, B., Dickersin, G. R., Ewing, S., Geller, S., Kasimian, D., et al. The National Polyp Study. Patient and polyp characteristics associated with high-grade dysplasia in colorectal adenomas. Gastroenterology, 98: 371-379, 1990. (Pubitemid 20037919)
57. Pfau, P. R., and Sivak, M. V., Jr. Endoscopic diagnostics. Gastroenterology, 120: 763-781, 2001. (Pubitemid 32171645)
58. Rex, D. K., Cutler, C. S., Lemmel, G. T., Rahmani, E. Y., Clark, D. W., Helper, D. J., Lehman, G. A., and Mark, D. G. Colonoscopic miss rates of adenomas determined by back-to-back colonoscopies. Gastroenterology, 112: 24-28, 1997. (Pubitemid 27008981)
59. Villavicencio, R. T., and Rex, D. K. Colonic adenomas: prevalence and incidence rates, growth rates, and miss rates at colonoscopy. Semin. Gastrointest. Dis., 11: 185-193, 2000.
60. Marten, K., Bremer, C., Khazaie, K., Tung, C. H., and Weissleder, R. Detection of dysplastic intestinal adenomas using enzyme sensing molecular beacons. Gastroenterology, 122: 406-414, 2002. (Pubitemid 34116992)
61. Kopans, D. B. Updated results of the trials of screening mammography. Surg. Oncol. Clin. N. Am., 6: 233-263, 1997. (Pubitemid 27187733)
62. Ntziachristos, V., Yodh, A. G., Schnall, M., and Chance, B. Concurrent MRI and diffuse optical tomography of breast after indocyanine green enhancement. Proc. Natl. Acad. Sci. USA, 97: 2767-2772, 2000. (Pubitemid 30159246)
63. Van Noorden, C. J., Jonges, T. G., Van Marle, J., Bissell, E. R., Griffini, P., Jans, M., Snel, J., and Smith, R. E. Heterogeneous suppression of experimentally induced colon cancer metastasis in rat liver lobes by inhibition of extracellular cathepsin B. Clin. Exp. Metastasis, 16: 159-167, 1998. (Pubitemid 28252923)
64. Ntziachristos, V., and Weissleder, R. In vivo optical imaging of molecular function using NIR fluorescent probes. In: J. Fujimoto and D. Farkas (eds.), Biomedical Optical Imaging, New York: Academic Press, 2003.
65. Ntziachristos, V., and Chance, B. Probing physiology and molecular function using optical imaging: applications to breast cancer. Breast Cancer Res. Treat., 3: 41-46, 2001. (Pubitemid 32223652)
66. Mycek, M. A., Schomacker, K. T., and Nishioka, N. S. Colonic polyp differentiation using time-resolved autofluorescence spectroscopy. Gastrointest. Endosc., 48: 390-394, 1998. (Pubitemid 28463160)
67. Mahmood, U., Tung, C. H., Tang, Y., and Weissleder, R. Feasibility of in vivo multi-channel optical imaging of gene expression: an experimental study in mice. Radiology, 224: 446-451, 2002. (Pubitemid 34809126)
68. Ntziachristos, V., and Weissleder, R. Experimental three-dimensional fluorescence reconstruction of diffuse media using a normalized Born approximation. Opt. Lett., 26: 893-895, 2001. (Pubitemid 33693607)
69. Ntziachristos, V., Chance, B., and Yodh, A. G. Differential diffuse optical tomography. Optics Express, 5: 230-242, 1999.